Why is Morepen Labs. falling/rising?

As of 12-Sep, Morepen Laboratories Ltd is experiencing a decline in its stock price, currently at 53.91, which reflects a decrease of 0.22 or 0.41%. The stock has underperformed its sector by 0.7% today and has shown a trend reversal after three consecutive days of gains. Although the stock has increased by 9.33% over the past week and 15.46% over the past month, it has a significant year-to-date decline of 31.15% and a one-year drop of 42.67%. The company has reported negative results for the last two consecutive quarters, with a notable fall in net sales and profits, which has contributed to the stock's recent downward movement. Despite a low debt-to-equity ratio and attractive valuation metrics, the lack of investor confidence, as indicated by the negligible domestic mutual fund holdings, suggests concerns about the company's growth prospects.
Broader market context indicates that while the Sensex has only declined by 1.28% over the past year, Morepen Laboratories Ltd's performance has been significantly worse, with a return of -42.67%. The stock's recent performance, including a rise in delivery volume, suggests some investor interest; however, the overall sentiment remains negative due to poor long-term growth and disappointing financial results. The stock's current price is also lower than its 50-day, 100-day, and 200-day moving averages, which may further discourage potential investors.